CLNN - Clene Inc.
4.54
0.140 3.084%
Share volume: 39,404
Last Updated: 03-11-2025
Pharmaceutical Products/Pharmaceutical Preparations:
0.03%
PREVIOUS CLOSE
CHG
CHG%
$4.40
0.14
0.03%
View ratios
| Fiscal Date | 03-31-2023 | 06-30-2023 | 09-30-2023 | 12-31-2023 | 03-31-2024 | 06-30-2024 | 09-30-2024 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 05-08-2024 | 08-14-2023 | 11-07-2023 | 11-13-2024 | 05-08-2024 | 08-07-2024 | 11-13-2024 | |
| Total revenue | 107.000 K | 269.000 K | 108.000 K | 170.000 K | 73.000 K | 91.000 K | 87.000 K | |
| Cost of revenue | 5.000 K | 66.000 K | 12.000 K | 38.000 K | 16.000 K | 18.000 K | 18.000 K | |
| Gross profit | 102.000 K | 203.000 K | 96.000 K | 132.000 K | 57.000 K | 73.000 K | 69.000 K | |
| 99.02% | -52.71% | 37.50% | -56.82% | 28.07% | -5.48% | |||
| Operating expenses | 10.834 M | 10.539 M | 9.638 M | 10.062 M | 9.289 M | 7.464 M | 7.884 M | |
| Selling general and admin | 3.439 M | 3.924 M | 3.666 M | 3.389 M | 3.420 M | 3.314 M | 3.413 M | |
| Research and development | 7.395 M | 6.615 M | 5.972 M | 6.673 M | 5.869 M | 4.150 M | 4.471 M | |
| Total expenses | 10.834 M | 10.539 M | 9.638 M | 10.062 M | 9.289 M | 7.464 M | 7.884 M | |
| -2.72% | -8.55% | 4.40% | -7.68% | -19.65% | 5.63% | |||
| Operating income | -10.732 M | -10.336 M | -9.542 M | -9.930 M | -9.232 M | -7.391 M | -7.815 M | |
| Ebit | -10.876 M | -24.252 M | -1.776 M | -9.431 M | -10.195 M | -5.772 M | -7.091 M | |
| Pretax income | -11.770 M | -25.143 M | -2.418 M | -10.173 M | -11.080 M | -6.785 M | -7.986 M | |
| 113.62% | -90.38% | 320.72% | 8.92% | -38.76% | 17.70% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -11.770 M | -25.143 M | -2.418 M | -10.173 M | -11.080 M | -6.785 M | -7.986 M | |
| -113.62% | 90.38% | -320.72% | -8.92% | 38.76% | -17.70% |